Navigation Links
Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants
Date:11/10/2010

WORCESTER, Mass., Nov. 10, 2010 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT) announced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.

The Antigen Express Therapeutic Discovery Projects are entitled:

  • Ii-Key Her-2/neu Peptide Vaccine, for the treatment of breast cancer
  • Ii-Key Her-2/neu Peptide Vaccine, for the treatment of prostate cancer

The proprietary vaccine being developed by Antigen Express is an off-the-shelf product designed to reduce the risk of relapse in cancer patients.  It is the subject of a controlled, randomized Phase II trial in patients with breast cancer which has yielded positive interim results.  Based on positive results from a Phase I trial in prostate cancer patients, preparations for a Phase II clinical trial in prostate cancer patients are underway.  In all studies, the self-potentiating vaccine has shown very low toxicity and generates a good immune response.  

The Therapeutic Discovery Project grants are targeted for projects that show a reasonable potential to: result in new therapies to treat areas of unmet medical need or prevent, detect, or treat chronic or acute diseases and conditions; reduce the long-term growth of health care costs in the United States; or, significantly advance the goal of curing cancer within 30 years.  Grant allocations also take into consideration which projects s
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board
2. Generex to Participate in Canadian Diabetes Association Conference
3. Generex Reschedules Live Video Webcast
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
6. Generex Provides Clarification for Special Meeting Voting
7. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
10. Generex Presents Abstract at EASD Annual Meeting
11. Generex Announces Sales Agreement with Elias Shaker & Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015 Research and Markets ( ... the "Wound Care -Traditonal, Advanced And ... And Forecasts" report to their offering. ... of the global Wound Care products market, ... offerings, competitive shares, financial performance, technology developments ...
(Date:7/27/2015)... 2015 According to the new ... (2014-2019) by Type (DNA ISH, RNA ISH), By Application ... (Hospitals, Pharma & Biotech Companies, Research Labs, CROs)", The ... 2014 and is estimated to reach $681.0 million by ... period, 2014 to 2019. Browse through the ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/v4wlnk/key_pharma_news ) has ... News Issue" newsletter to their offering. ... oncology pipeline and serves as a statement of ... 2015, with a large-scale potentially transformative acquisition by ... Pharma News covers all major developments in the ...
Breaking Medicine Technology:Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3
... Colo., Oct. 14, 2011 Data presented at ... in Chicago, IL show that the pretreatment blood-based ... carcinoma (RCC) patients treated with a combination of ... by survival outcomes.   Patients who tested VeriStrat ...
... Pharmaceuticals, Inc. announced Friday a significant expansion of its ... methyl, and to continue advancing its earlier-stage pipeline. ... Paul Audhya, MD, as Vice President of ... Ph.D., as Vice President and Chief Regulatory and Compliance ...
Cached Medicine Technology:VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 2VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
(Date:7/28/2015)... , ... July 28, 2015 , ... Want to improve ... – or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises ... an orthopedic spine surgeon at Atlantic Spine Center . , It’s simply ...
(Date:7/27/2015)... , ... July 28, 2015 , ... Almost a year ... to offer behavioral health counseling for persons who are obese and those who are ... less clear. , That mandate will affect any commercial health plan with a program ...
(Date:7/27/2015)... (PRWEB) , ... July 28, 2015 , ... The ... 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is recognized ... over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for ...
(Date:7/27/2015)... , ... July 27, 2015 , ... The heroin epidemic ... reported WCNC on July 7th. The rate for heroin usage has continued ... gone down considerably, and is a less expensive alternative for those with an addiction ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Looking to ... smile? Horizon Blue Cross Blue Shield of New Jersey has enhanced its Dental webpage ... take care of their teeth. , “Horizon is committed to offering our 3.8 ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... reimburses patients and physicians who have been shortchanged ... American Medical Association (AMA), along with the Medical Society ... State Medical Association, claims victory with the settlement agreement ... The $350 million settlement marks the largest monetary settlement ...
... Philadelphia Attorney Stephen Sheller,s Whistleblower Clients Help ... Criminal Fine in Eli Lilly & Company ... 2003 Representing Six Whistleblowers PHILADELPHIA, Jan. 15 ... ("Lilly") will pay federal and state governments ...
... Eli Lilly and Company announced today it has ... pay more than 1.4 billion in criminal and civil ... multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, ... with its market practices for its blockbuster atypical antipsychotic, ...
... transplanted because of the generosity of donors and their familiesPHILADELPHIA, ... kid on the football field, but he spent his life ... graduated high school. For a 16-year-old from Hazleton, Pa. ... certainly unique. But as his father Paul Sr. talked ...
... $515 Million Criminal Fine is Largest Individual Corporate Criminal ... 15 American pharmaceutical giant Eli Lilly and Company ... for promoting its drug Zyprexa for uses not approved ... of Justice announced today. This resolution includes ...
... CINCINNATI, Jan. 15, 2009 The Procter & Gamble,Company ... organizational changes: , -- Mariano ... June 30, 2009, after 33 years of service. He ... 2009, when he will focus on working,closely with his ...
Cached Medicine News:Health News:AMA Claims Victory With Record Breaking Settlement in Case Against Insurer 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 3Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 4Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 2Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 3Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 2Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 3Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 5Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 6Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 7Health News:Procter & Gamble Announces Organizational Changes 2